Small-Cap Healthcare Stocks — Analysis & Financial Data
Small-Cap Healthcare stocks are the healthcare companies inside the small-cap band. Invest Viable tracks 171 small-cap healthcare stocks with proprietary Investment Scores and base valuations to help you evaluate which names look fairly priced and which may offer a margin of safety.
Explore 171 Stocks →- Stocks
- 171
- Avg. Score / 100
- 35
- Sector
- Healthcare
- Updated
- 2026-09-09
Small-Cap Healthcare Stock List
| Company | Price | Base Earnings FV | Score | Market Cap | P/E | EPS | Yield |
|---|---|---|---|---|---|---|---|
Capricor Therapeutics, Inc. CAPR | $8.64 | — | 23 | $382M | -2.7 | $-704.73 | 0.00% |
Lexeo Therapeutics, Inc. LXEO | $4.48 | — | 26 | $380M | -4.2 | $-1.02 | 0.00% |
Rocket Pharmaceuticals, Inc. RCKT | $3.63 | — | 32 | $379M | -21.7 | $-0.15 | 0.00% |
Alpha Teknova, Inc. TKNO | $6.96 | — | 23 | $375M | -22.2 | $-0.31 | 0.00% |
Upstream Bio, Inc. UPB | $5.96 | — | 29 | $373M | -2.4 | $-2.87 | 0.00% |
Palisade Bio, Inc. PALI | $2.05 | — | 26 | $371M | -4.0 | $-0.15 | 0.00% |
Senseonics Holdings, Inc. SENS | $8.72 | — | 26 | $369M | -3.9 | $-1.89 | 0.00% |
Foghorn Therapeutics Inc. FHTX | $4.67 | — | 35 | $368M | -6.3 | $-0.91 | 0.00% |
DiaMedica Therapeutics Inc. DMAC | $6.59 | — | 19 | $360M | -9.3 | $-0.70 | 0.00% |
Sagimet Biosciences Inc. SGMT | $10.86 | — | 23 | $344M | -8.2 | $-0.89 | 0.00% |
Lyell Immunopharma, Inc. LYEL | $12.88 | — | 26 | $342M | -0.9 | $-10.64 | 0.00% |
SAB Biotherapeutics, Inc. SABS | $3.48 | — | 35 | $337M | 3.0 | $-0.16 | 0.00% |
Prenetics Global Limited PRE | $24.27 | — | 45 | $336M | -4.3 | $-4.18 | 0.00% |
Viemed Healthcare, Inc. VMD | $8.76 | $8.68 | 84 | $326M | 22.7 | $0.38 | 0.00% |
Keros Therapeutics, Inc. KROS | $11.31 | — | 52 | $323M | -2.7 | $-4.20 | 0.00% |
CapsoVision, Inc. CV | $6.37 | — | 19 | $323M | -8.1 | $-0.60 | 0.00% |
TriSalus Life Sciences, Inc. TLSI | $4.76 | — | 26 | $322M | -4.0 | $-0.48 | 0.00% |
Inhibikase Therapeutics, Inc. IKT | $2.41 | — | 35 | $318M | -5.1 | $-0.35 | 0.00% |
Prelude Therapeutics Incorporated PRLD | $5.09 | — | 32 | $316M | -7.0 | $-0.61 | 0.00% |
Agenus Inc. AGEN | $6.86 | — | 32 | $305M | 2.7 | $2.23 | 0.00% |
Embecta Corp. EMBC | $5.12 | — | 48 | $303M | 3.4 | $1.50 | 9.02% |
About Small-Cap Healthcare Stocks
Small-Cap Healthcare stocks are the healthcare names that sit inside one market-cap band. This screener narrows the broader Healthcare universe down to 171 companies with a market capitalization between $300 million and $2 billion. The average Investment Score across the 171 qualifying stocks is 35/100, ranked here by market capitalization.
How this screen works
Every stock on this list is classified as a Healthcarecompany per GICS sector taxonomy, the industry-standard classification used across the major index providers, and ingested into Invest Viable's data pipeline daily. Each company is then evaluated against our 28-check Investment Score framework. The checks sit in three categories: Valuation (price against the three base valuations and against earnings, book value, sales and EBITDA, each at a fixed threshold), Financial Strength (interest and debt coverage, leverage, liquidity, and the trend in margins and free cash flow) and Performance (revenue and earnings growth, consistency and quality, returns on equity, assets and invested capital, and free cash flow generation). Most checks are pass or fail, scoring one point or zero; a small number use a three-tier scale. The points earned are divided by a fixed denominator of 31 and scaled to 0–100.
The Small-Cap filter applied on this page is a market-cap band layered on top of that scoring, not a quality judgment. Companies outside a market capitalization between $300 million and $2 billion remain on the broader Healthcare screener, and each appears on the size screen for its own band; names under $300 million sit on the Micro-Cap screener. Because market cap tracks the share price, a name sitting near a boundary can cross it between data refreshes without anything changing inside the business.
Because the same 28-check framework runs across every screener page on Invest Viable, the Investment Scores on this page are directly comparable to those on the broader Healthcare screener, on any of the four investment style screeners, or on any other intersection in our catalog. A score of 72 here means what it means anywhere on the site: the same 28 checks, the same thresholds, the same fixed denominator. The score is descriptive. It reports what a company's financials currently look like, not what they will do next, and it is not a recommendation to buy or sell.
Frequently asked questions
What are Small-Cap Healthcare stocks?
Small-Cap Healthcare stocks are healthcare-sector companies with a market capitalization between $300 million and $2 billion. The band is mechanical: the list is every covered healthcare name whose market cap currently sits inside it, which comes to 171 today.
How is this different from the broader Healthcare screener?
The Healthcare sector screener covers every healthcare stock in the Invest Viable universe at any size. This page adds one filter, a market capitalization between $300 million and $2 billion, which leaves 171 names. Market caps move with price, so a company can cross into or out of this list between data refreshes.
What is the typical Investment Score range for Small-Cap Healthcare stocks?
The average Investment Score across the 171 stocks on this list is 35/100. Investment Scores come from our 28-check framework, grouped into Valuation, Financial Strength and Performance. Higher scores mean more points earned across those checks, each against a fixed threshold; the score is descriptive, not a buy or sell signal.
Why are some Healthcare stocks missing from this list?
The only filter here is size (a market capitalization between $300 million and $2 billion). A healthcare company outside that band is not excluded from the site: it stays on the Healthcare screener and, where another band covers it, on that size screen; names below $300 million are covered on the Micro-Cap screener.
Are these screens investment recommendations?
No. Invest Viable provides methodology and data; investment decisions are the user's responsibility. The screens surface stocks matching specific criteria; they do not endorse any stock for purchase or sale.
Explore more combinations
Other intersections that use the same screening framework.
Find undervalued small-cap healthcare stocks with professional valuation tools
Set your own price targets using DCF, EBITDA multiples, and Graham Fair Value methods. Compare your valuations against our base estimates and make confident investment decisions.
Disclaimer: The information provided on this page is for informational and educational purposes only and does not constitute investment advice, financial advice, or any recommendation to buy, sell, or hold any security. Investment Scores, base valuations, and fair value estimates are generated using proprietary models and should not be the sole basis for any investment decision. All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Invest Viable Global AB is not a registered investment advisor.